Safety of Lenalidomide (Len) 10Mg in Non-Del(5Q) Versus Del(5Q) in the Treatment of Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (Mds): Pooled Analysis of Treatment-Emergent Adverse Events (Teaes)
AuthID
P-00K-6FZ
P-00K-6FZ